ICU Medical (NASDAQ:ICUI) Trading Down 6.2% After Analyst Downgrade

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report)'s share price dropped 6.2% during trading on Tuesday after StockNews.com downgraded the stock from a buy rating to a hold rating. The stock traded as low as $132.95 and last traded at $128.29. Approximately 118,240 shares changed hands during mid-day trading, a decline of 56% from the average daily volume of 269,985 shares. The stock had previously closed at $136.72.

Other analysts have also recently issued research reports about the stock. Raymond James set a $97.00 price objective on shares of ICU Medical in a research note on Wednesday, March 12th. KeyCorp dropped their price target on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Finally, Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Two analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $162.67.

Institutional Investors Weigh In On ICU Medical

A number of large investors have recently bought and sold shares of ICUI. Arizona State Retirement System lifted its holdings in shares of ICU Medical by 1.0% during the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after acquiring an additional 65 shares during the period. Huntington National Bank increased its stake in shares of ICU Medical by 6.2% in the fourth quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock valued at $218,000 after buying an additional 82 shares during the period. Equitable Trust Co. lifted its position in shares of ICU Medical by 1.6% in the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after purchasing an additional 84 shares during the period. LPL Financial LLC grew its holdings in ICU Medical by 2.0% during the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock worth $747,000 after acquiring an additional 93 shares during the period. Finally, Alliancebernstein L.P. increased its holdings in ICU Medical by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock worth $4,051,000 after purchasing an additional 136 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Stock Down 1.1 %

The firm's 50 day moving average price is $143.81 and its two-hundred day moving average price is $158.07. The company has a market cap of $3.34 billion, a P/E ratio of -29.68 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.